Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Trimethlyamine-N-oxide (TMAO) was recently identified as a promoter of atherosclerosis. Patients with CKD exhibit accelerated development of atherosclerosis; however, no studies have explored the relationship between TMAO and atherosclerosis formation in this group. This study measured serum concentrations and urinary excretion of TMAO in a CKD cohort (n=104), identified the effect of renal transplant on serum TMAO concentration in a subset of these patients (n=6), and explored the cross-sectional relationship between serum TMAO and coronary atherosclerosis burden in a separate CKD cohort (n=220) undergoing coronary angiography. Additional exploratory analyses examined the relationship between baseline serum TMAO and long-term survival after coronary angiography. Serum TMAO concentrations demonstrated a strong inverse association with eGFR (r(2)=0.31, P<0.001). TMAO concentrations were markedly higher in patients receiving dialysis (median [interquartile range], 94.4 μM [54.8-133.0 μM] for dialysis-dependent patients versus 3.3 μM [3.1-6.0 μM] for healthy controls; P<0.001); whereas renal transplantation resulted in substantial reductions in TMAO concentrations (median [min-max] 71.2 μM [29.2-189.7 μM] pretransplant versus 11.4 μM [8.9-20.2 μM] post-transplant; P=0.03). TMAO concentration was an independent predictor for coronary atherosclerosis burden (P=0.02) and predicted long-term mortality independent of traditional cardiac risk factors (hazard ratio, 1.26 per 10 μM incr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the peak plasma TMAO levels with this protocol were similar to levels observed in mice chronically exposed to the choline‐supplemented diet (Figure 1C) and in some human clinical studies.9, 10, 17”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [10]
In the citing paper
“Numerous recent case–control and longitudinal studies have shown a striking association between trimethylamine N‐oxide (TMAO) levels and cardiovascular disease risks in a variety of cohorts.1, 2, 3, 4, 5, 6, 7, 8, 9, 10”
From Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB (2016) · cites this paper as [10]
In the citing paper
“Other studies revealed that TMAO is augmented in renal insufficiency but concentrations normalize after renal transplantation [48]”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [48]
In the citing paper
“Among the prospective studies, 5 studies10, 13, 19, 20, 23 did not find a significantly elevated RR in the highest category of TMAO levels as compared with the lowest category, in either unadjusted or multivariate‐adjusted models among total participants.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [19]
In the citing paper
“Nonetheless, median values of TMAO concentrations in healthy individuals were reported as ranges of 3 to 6 μmol/L,8, 17, 18, 19 and the study by Shafi et al22 consisted of hemodialysis patients with the substantially high mean vale of TMAO (101.9 μmol/L among total participants).”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [19]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
A more meaningful scoring system for determining the severity of coronary heart disease
Gensini, G. G. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80105-2 · Cited by 2,168
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Epidemiology of cardiovascular disease in chronic renal disease.
Foley, R. N., Parfrey, P. S., & Sarnak, M. J. (1998) · PubMed · Cited by 1,252
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Chronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
Port, F. K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510110079036 · Cited by 825
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ramezani, A., & Raj, D. S. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080905 · Cited by 743
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559
Jungers, P., Massy, Z., Khoa, T., Fumeron, C., Labrunie, M., Lacour, B., Descamps-Latscha, B., & Man, N. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2597 · Cited by 321 · cited 2×
“Potential limitations of this work include: (1) a lack of ethnic diversity (90% Caucasian) which may affect the generalizability of our findings to other populations with CKD; (2) limited inclusion of outcomes data from patients with ESRD, which are the subset of patients with CKD with the highest concentrations of TM…”
BackgroundMethodLang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Hida, M., Aiba, Y., Sawamura, S., Suzuki, N., Satoh, T., & Koga, Y. (2008) · Nephron · doi:10.1159/000189334 · Cited by 295
Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282
Clinical subtypes of Alzheimer’s disease
Petersen, R. C. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051199 · Cited by 223
Cardiovascular risk factors in chronic kidney disease
Menon, V., Gul, A., & Sarnak, M. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00551.x · Cited by 206
Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction
Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z., & Liu, S. (2013) · American Journal of Nephrology · doi:10.1159/000353764 · Cited by 195
Metabolite Profiling Identifies Markers of Uremia
Rhee, E. P., Souza, A., Farrell, L., Pollak, M. R., Lewis, G. D., Steele, D. J. R., Thadhani, R., Clish, C. B., Greka, A., & Gerszten, R. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111132 · Cited by 184
Magnusson, M., Magnusson, K. E., Sundqvist, T., & Denneberg, T. (1991) · Gut · doi:10.1136/gut.32.7.754 · Cited by 143
The metabolism of14C-labelled trimethylamine and its N-oxide in man
Al-waiz, M., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987) · Xenobiotica · doi:10.3109/00498258709043962 · Cited by 143
The risk of atherosclerosis in patients with chronic kidney disease
Olechnowicz-Tietz, S., Gluba, A., Paradowska, A., Banach, M., & Rysz, J. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0407-1 · Cited by 105
Bacterial translocation in experimental uremia
Duarte, J. B. D. A., de Aguilar‐Nascimento, J. E., Nascimento, M., & Nochi, R. J. (2003) · Urological Research · doi:10.1007/s00240-003-0381-7 · Cited by 85
Magnusson, M., Magnusson, K.-E., Sundqvist, T., & Denneberg, T. (1990) · Nephron · doi:10.1159/000186158 · Cited by 73
Lindsey, J. B., House, J. A., Kennedy, K. F., & Marso, S. P. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.876672 · Cited by 72
Self-citationOcque, A. J., Stubbs, J. R., & Nolin, T. D. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.040 · Cited by 68
Self-citationMarso, S. P., Mehta, S. K., Frutkin, A. D., House, J. A., McCrary, J. R., & Kulkarni, K. R. (2008) · Diabetes Care · doi:10.2337/dc07-2024 · Cited by 61
Self-citationExpression of Scavenger Receptor CD36 in Chronic Renal Failure Patients
Chmielewski, M., Bryl, E., Marzec, L., Aleksandrowicz, E., Witkowski, J. M., & Rutkowski, B. (2005) · Artificial Organs · doi:10.1111/j.1525-1594.2005.29097.x · Cited by 48
Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients
Ando, M., Lundkvist, I., Bergström, J., & Lindholm, B. (1996) · Kidney International · doi:10.1038/ki.1996.107 · Cited by 48
Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1
Zuo, Y., Yancey, P., Castro, I., Khan, W., Motojima, M., Ichikawa, I., Fogo, A. B., Linton, M. F., Fazio, S., & Kon, V. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.188995 · Cited by 39
Ando, M., Gåfvels, M. E., Bergström, J. P., Lindholm, B., & Lundkvist, I. (1997) · Kidney International · doi:10.1038/ki.1997.110 · Cited by 35
MITCHELL, S. C., ZHANG, A. Q., NOBLET, J. M. D., GILLESPIE, S., JONES, N., & SMITH, R. L. (1997) · Xenobiotica · doi:10.1080/004982597239949 · Cited by 26
Wu, C., Chen, J., Lin, S., Chu, P., Lin, Y., Lin, S., & Liao, T. (2005) · Artificial Organs · doi:10.1111/j.1525-1594.2005.29110.x · Cited by 14
Konishi, Y., Okamura, M., Konishi, M., Negoro, N., Yoshida, T., Inoue, T., Kanayama, Y., & Yoshikawa, J. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.6.1167 · Cited by 14
Cited by
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
“They have been implicated as causal factors for CKD-related cardiovascular disease (155, 457), bone disorders (155), gout (470), cachexia/sarcopenia (409), atherosclerosis (212, 450), stroke (22), dementia (22), diabetes (250), hypertension (312), and anemia (78).”
BackgroundSeldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911
“in mice chronically exposed to the choline-supplemented diet (Figure 1C) and in some human clinical studies.(9,10,17) At Figure 1.”
BackgroundDietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
“Other studies revealed that TMAO is augmented in renal insufficiency but concentrations normalize after renal transplantation [48] and levels are higher the more the glomerular filtration rate GFR is reduced [49].”
Background
Metadata
- Authors
- Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., Spertus, J. A., & Yu, A. S.
- Affiliations
- University of Kansas Medical Center (US)
- Hennepin County Medical Center (US)
- University of Pittsburgh (US)
- Saint Luke's Hospital (US)
- Corresponding author
- Stubbs, Jason R.
- Zhang, Shiqin
- Johnson, Cassandra
- Schmidt, Kyle
- Gupta, Aditi
- Spertus, John A.
- Yu, Alan S.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2016-01
- Volume
- 27
- Issue
- 1
- Pages
- 305-313
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4696571
- OpenAlex
- W1828622309
- Cited by
- 450
- References
- 41
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 38 · 2023: 42 · 2022: 59 · 2021: 56 · 2020: 56 · 2019: 30 · 2018: 40 · 2017: 28 · 2016: 26
- FWCI
- 29.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000001)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK071496)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- trimethylamine N-oxide, chronic kidney disease, coronary artery disease, kidney transplantation, dialysis, estimated glomerular filtration rate, long-term mortality, atherosclerosis risk factors
- MeSH terms
- Aged, Coronary Artery Disease, Cross-Sectional Studies, Female, Humans, Male, Methylamines, Prospective Studies, Kidney Transplantation, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.